1. Home
  2. NVAX vs VEON Comparison

NVAX vs VEON Comparison

Compare NVAX & VEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • VEON
  • Stock Information
  • Founded
  • NVAX 1987
  • VEON 1992
  • Country
  • NVAX United States
  • VEON Netherlands
  • Employees
  • NVAX N/A
  • VEON N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • VEON Telecommunications Equipment
  • Sector
  • NVAX Health Care
  • VEON Telecommunications
  • Exchange
  • NVAX Nasdaq
  • VEON Nasdaq
  • Market Cap
  • NVAX 2.0B
  • VEON 2.1B
  • IPO Year
  • NVAX 1995
  • VEON 1996
  • Fundamental
  • Price
  • NVAX $9.76
  • VEON $30.33
  • Analyst Decision
  • NVAX Buy
  • VEON
  • Analyst Count
  • NVAX 6
  • VEON 0
  • Target Price
  • NVAX $17.83
  • VEON N/A
  • AVG Volume (30 Days)
  • NVAX 7.2M
  • VEON 29.2K
  • Earning Date
  • NVAX 11-07-2024
  • VEON 11-14-2024
  • Dividend Yield
  • NVAX N/A
  • VEON N/A
  • EPS Growth
  • NVAX N/A
  • VEON N/A
  • EPS
  • NVAX N/A
  • VEON N/A
  • Revenue
  • NVAX $987,667,000.00
  • VEON $3,867,000,000.00
  • Revenue This Year
  • NVAX N/A
  • VEON $11.98
  • Revenue Next Year
  • NVAX N/A
  • VEON $7.27
  • P/E Ratio
  • NVAX N/A
  • VEON $7.05
  • Revenue Growth
  • NVAX N/A
  • VEON 6.53
  • 52 Week Low
  • NVAX $3.53
  • VEON $15.10
  • 52 Week High
  • NVAX $23.86
  • VEON $32.69
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 36.20
  • VEON 53.19
  • Support Level
  • NVAX $9.52
  • VEON $30.10
  • Resistance Level
  • NVAX $10.63
  • VEON $32.00
  • Average True Range (ATR)
  • NVAX 0.57
  • VEON 0.99
  • MACD
  • NVAX -0.12
  • VEON -0.04
  • Stochastic Oscillator
  • NVAX 9.97
  • VEON 50.37

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

About VEON VEON Ltd. ADS

VEON Ltd is a global provider of connectivity and internet services. The company provides its customers with voice, fixed broadband, data, and digital services. Currently, the company offers services to customers in the following countries: Pakistan, Ukraine, Kazakhstan, Bangladesh, Uzbekistan, and Kyrgyzstan. The reportable segments currently consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. The company provides services under the Beeline, Kyivstar, banglalink and Jazz brands.

Share on Social Networks: